Exelixis Inc Increase (Decrease) in Other Noncurrent Assets
Exelixis Inc (EXEL) reported Increase (Decrease) in Other Noncurrent Assets of $6.29 million for the 9-month period ending 2019-09-27, per its 10-Q filed 2019-10-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2019-10-30
- Exelixis Inc increase (decrease) in other noncurrent assets for the quarter ending 2019-09-27 was $1.50M, a 176.15% increase year-over-year.
- Exelixis Inc increase (decrease) in other noncurrent assets for the quarter ending 2019-06-28 was -$65.00K.
- Exelixis Inc increase (decrease) in other noncurrent assets for the quarter ending 2019-03-29 was $4.85M, a 1302.89% increase year-over-year.
- Exelixis Inc increase (decrease) in other noncurrent assets for the quarter ending 2018-12-28 was $544.00K, a 110.04% increase year-over-year.
- Exelixis Inc increase (decrease) in other noncurrent assets for fiscal 2018 was $1.09M.
- Exelixis Inc increase (decrease) in other noncurrent assets for fiscal 2017 was -$430.00K.
- Exelixis Inc increase (decrease) in other noncurrent assets for fiscal 2016 was -$1.08M.
- Exelixis Inc increase (decrease) in other noncurrent assets for fiscal 2016 was -$1.08M.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2019-09-27 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.44M derived: sum of 2 quarters · filed 2019-10-30 | $6.29M 10-Q · filed 2019-10-30 | $6.84M derived: sum of 4 quarters · filed 2019-10-30 |
| 2019-06-28 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $4.79M 10-Q · filed 2019-07-31 | $5.33M derived: sum of 3 quarters · filed 2019-07-31 | $5.88M derived: sum of 4 quarters · filed 2019-10-30 |
| 2019-03-29 | $4.85M 10-Q · filed 2019-05-01 | $5.40M derived: sum of 2 quarters · filed 2019-05-01 | $5.94M derived: sum of 3 quarters · filed 2019-10-30 | $5.59M derived: sum of 4 quarters · filed 2019-10-30 |
| 2018-12-28 | $544.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $1.09M derived: sum of 2 quarters · filed 2019-10-30 | $740.00K derived: sum of 3 quarters · filed 2019-10-30 | $1.09M 10-K · filed 2019-02-22 |
| 2018-09-28 | $545.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $196.00K derived: sum of 2 quarters · filed 2019-10-30 | $542.00K 10-Q · filed 2019-10-30 | $801.00K derived: sum of 4 quarters · filed 2019-10-30 |
| 2018-06-29 | -$349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$3.00K 10-Q · filed 2019-07-31 | $256.00K derived: sum of 3 quarters · filed 2019-07-31 | $86.00K derived: sum of 4 quarters · filed 2019-07-31 |
| 2018-03-30 | $346.00K 10-Q · filed 2019-05-01 | $605.00K derived: sum of 2 quarters · filed 2019-05-01 | $435.00K derived: sum of 3 quarters · filed 2019-05-01 | |
| 2017-12-29 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $89.00K derived: sum of 2 quarters · filed 2019-02-22 | -$430.00K 10-K · filed 2019-02-22 | |
| 2017-09-30 | -$170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$689.00K 10-Q · filed 2017-11-01 | ||
| 2017-09-29 | -$170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$708.00K derived: sum of 2 quarters · filed 2018-11-01 | -$689.00K 10-Q · filed 2018-11-01 | -$1.23M derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | -$538.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$519.00K 10-Q · filed 2017-08-02 | -$1.06M derived: sum of 3 quarters · filed 2018-05-02 | -$1.50M derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-03-31 | $19.00K 10-Q · filed 2017-05-01 | -$523.00K derived: sum of 2 quarters · filed 2018-05-02 | -$959.00K derived: sum of 3 quarters · filed 2018-05-02 | -$817.00K derived: sum of 4 quarters · filed 2018-05-02 |
| 2016-12-31 | -$542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$978.00K derived: sum of 2 quarters · filed 2017-11-01 | -$836.00K derived: sum of 3 quarters · filed 2017-11-01 | -$1.08M 10-K · filed 2017-02-27 |
| 2016-12-30 | -$1.08M 10-K · filed 2019-02-22 | |||
| 2016-09-30 | -$436.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$294.00K derived: sum of 2 quarters · filed 2017-11-01 | -$535.00K 10-Q · filed 2017-11-01 | -$43.00K derived: sum of 4 quarters · filed 2017-11-01 |
| 2016-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$99.00K 10-Q · filed 2017-08-02 | $393.00K derived: sum of 3 quarters · filed 2017-08-02 | -$1.24M derived: sum of 4 quarters · filed 2017-08-02 |
| 2016-03-31 | -$241.00K 10-Q · filed 2017-05-01 | $251.00K derived: sum of 2 quarters · filed 2017-05-01 | -$1.38M derived: sum of 3 quarters · filed 2017-05-01 | -$1.70M derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-01-01 | -$1.34M 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$1.14M derived: sum of 2 quarters · filed 2017-02-27 | -$1.46M derived: sum of 3 quarters · filed 2017-02-27 | -$1.34M 10-K · filed 2017-02-27 |
| 2015-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.95M derived: sum of 2 quarters · filed 2016-11-03 | -$1.83M 10-Q · filed 2016-11-03 | |
| 2015-06-30 | -$317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$202.00K 10-Q · filed 2016-08-03 | ||
| 2015-03-31 | $115.00K 10-Q · filed 2016-05-04 | |||
| 2014-12-31 | $2.15M 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |